https://www.selleckchem.com/pr....oducts/triton-tm-x-1
Overall, CDR132L treatment significantly improved cardiac function and reversed cardiac remodelling. In addition to the systolic recovery, diastolic function was also ameliorated in this chronic model of HF. Monthly repeated dosing of CDR132L is safe and adequate to provide clinically relevant exposure and therapeutic efficacy in a model of chronic post-MI HF. CDR132L thus should be explored as treatment for the broad area of chronic heart failure. Monthly repeated dosing of CDR132L is safe and adequate to provide clinically rel
Like
Comment
Share
